Anthropic Accelerates Drug Discovery Partnerships and Launches Claude Science Platform

Anthropic has established deep research partnerships with six organizations developing new medicines and launched its own drug discovery programs, marking a significant expansion into pharmaceutical AI. The company revealed it has engaged in ongoing collaborations with BigHat Biosciences, Bristol Myers Squibb, Divergence Labs, Enveda, Generate Biomedicines, and The Column Group. Simultaneously, Anthropic started drug discovery efforts of its own, including programs focused on rare childhood forms of muscular dystrophy where Claude handles much of the scientific and operational work.